Literature DB >> 10490596

Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.

R Fenrick1, J M Amann, B Lutterbach, L Wang, J J Westendorf, J R Downing, S W Hiebert.   

Abstract

t(12;21) is the most frequent translocation found in pediatric B-cell acute lymphoblastic leukemias. This translocation fuses a putative repressor domain from the TEL DNA-binding protein to nearly all of the AML-1B transcription factor. Here, we demonstrate that fusion of the TEL pointed domain to the GAL4 DNA-binding domain resulted in sequence-specific transcriptional repression, indicating that the pointed domain is a portable repression motif. The TEL pointed domain functioned equally well when the GAL4 DNA-binding sites were moved 600 bp from the promoter, suggesting an active mechanism of repression. This lead us to demonstrate that wild-type TEL and the t(12;21) fusion protein bind the mSin3A corepressor. In the fusion protein, both TEL and AML-1B contribute mSin3 interaction domains. Deletion mutagenesis indicated that both the TEL and AML-1B mSin3-binding domains contribute to repression by the fusion protein. While both TEL and AML-1B associate with mSin3A, TEL/AML-1B appears to bind this corepressor much more stably than either wild-type protein, suggesting a mode of action for the t(12;21) fusion protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490596      PMCID: PMC84626          DOI: 10.1128/MCB.19.10.6566

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  69 in total

1.  The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription.

Authors:  S W Hiebert; W Sun; J N Davis; T Golub; S Shurtleff; A Buijs; J R Downing; G Grosveld; M F Roussell; D G Gilliland; N Lenny; S Meyers
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  Biallelic alterations of both ETV6 and CDKN1B genes in a t(12;21) childhood acute lymphoblastic leukemia case.

Authors:  I Wlodarska; M Baens; P Peeters; J Aerssens; C Mecucci; P Brock; P Marynen; H Van den Berghe
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

3.  The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.

Authors:  M Carroll; M H Tomasson; G F Barker; T R Golub; D G Gilliland
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 4.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

5.  Groucho-dependent and -independent repression activities of Runt domain proteins.

Authors:  B D Aronson; A L Fisher; K Blechman; M Caudy; J P Gergen
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

6.  Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.

Authors:  H Uchida; J R Downing; Y Miyazaki; R Frank; J Zhang; S D Nimer
Journal:  Oncogene       Date:  1999-01-28       Impact factor: 9.867

7.  ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.

Authors:  S R Knezevich; M J Garnett; T J Pysher; J B Beckwith; P E Grundy; P H Sorensen
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

8.  Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21).

Authors:  S P Romana; M Le Coniat; H Poirel; P Marynen; O Bernard; R Berger
Journal:  Leukemia       Date:  1996-01       Impact factor: 11.528

9.  Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.

Authors:  T Miyamoto; K Nagafuji; K Akashi; M Harada; T Kyo; T Akashi; K Takenaka; S Mizuno; H Gondo; T Okamura; H Dohy; Y Niho
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

10.  The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia.

Authors:  S Raynaud; H Cave; M Baens; C Bastard; V Cacheux; J Grosgeorge; C Guidal-Giroux; C Guo; E Vilmer; P Marynen; B Grandchamp
Journal:  Blood       Date:  1996-04-01       Impact factor: 22.113

View more
  43 in total

1.  Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1.

Authors:  S H Yang; E Vickers; A Brehm; T Kouzarides; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression.

Authors:  C A Kim; M L Phillips; W Kim; M Gingery; H H Tran; M A Robinson; S Faham; J U Bowie
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

3.  Folylpolyglutamate synthetase gene transcription is regulated by a multiprotein complex that binds the TEL-AML1 fusion in acute lymphoblastic leukemia.

Authors:  Guy J Leclerc; Christopher Sanderson; Stephen Hunger; Meenakshi Devidas; Julio C Barredo
Journal:  Leuk Res       Date:  2010-06-09       Impact factor: 3.156

4.  The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.

Authors:  A Buijs; L van Rompaey; A C Molijn; J N Davis; A C Vertegaal; M D Potter; C Adams; S van Baal; E C Zwarthoff; M F Roussel; G C Grosveld
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation.

Authors:  Kazuhiro Maki; Honoka Arai; Kazuo Waga; Ko Sasaki; Fumihiko Nakamura; Yoichi Imai; Mineo Kurokawa; Hisamaru Hirai; Kinuko Mitani
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 6.  Dual-function transcription factors and their entourage: unique and unifying themes governing two pathogenesis-related genes.

Authors:  Patrick Boyle; Charles Després
Journal:  Plant Signal Behav       Date:  2010-06-01

7.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 8.  Runx1/AML1 in normal and abnormal hematopoiesis.

Authors:  Tetsuya Yamagata; Kazuhiro Maki; Kinuko Mitani
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

9.  The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor.

Authors:  Iver Nordentoft; Poul Jørgensen
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival.

Authors:  S Wotton; A Terry; A Kilbey; A Jenkins; P Herzyk; E Cameron; J C Neil
Journal:  Oncogene       Date:  2008-06-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.